313 related articles for article (PubMed ID: 30013957)
1. Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography.
Lee MW; Lim HK; Rhim H; Cha DI; Kang TW; Song KD; Min JH; Gwak GY; Kim S; Lu DSK
Can J Gastroenterol Hepatol; 2018; 2018():7926923. PubMed ID: 30013957
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasonography-CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome.
Lee Y; Yoon JH; Han S; Joo I; Lee JM
Cancer Imaging; 2024 Jan; 24(1):4. PubMed ID: 38172949
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced ultrasound-guided radiofrequency ablation in inconspicuous hepatocellular carcinoma on B-mode ultrasound.
Kim EJ; Kim YS; Shin SK; Kwon OS; Choi DJ; Kim JH
Turk J Gastroenterol; 2017 Nov; 28(6):446-452. PubMed ID: 29086712
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US.
Min JH; Lim HK; Lim S; Kang TW; Song KD; Choi SY; Rhim H; Lee MW
Clin Mol Hepatol; 2014 Mar; 20(1):61-70. PubMed ID: 24757660
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography.
Kim AY; Lee MW; Rhim H; Cha DI; Choi D; Kim YS; Lim HK; Cho SW
Korean J Radiol; 2013; 14(5):754-63. PubMed ID: 24043968
[TBL] [Abstract][Full Text] [Related]
7. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
[TBL] [Abstract][Full Text] [Related]
8. Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging.
Minami T; Minami Y; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Inoue T; Hagiwara S; Ueshima K; Nishida N; Kudo M
Oncology; 2014; 87 Suppl 1():55-62. PubMed ID: 25427734
[TBL] [Abstract][Full Text] [Related]
9. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Wang D; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K
Br J Radiol; 2016 Nov; 89(1067):20160379. PubMed ID: 27626506
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography.
Park HJ; Lee MW; Rhim H; Cha DI; Kang TW; Lim S; Song KD; Lim HK
Clin Radiol; 2015 Apr; 70(4):387-94. PubMed ID: 25582889
[TBL] [Abstract][Full Text] [Related]
11. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
[TBL] [Abstract][Full Text] [Related]
12. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
[TBL] [Abstract][Full Text] [Related]
13. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
[No Abstract] [Full Text] [Related]
14. Thermal ablation with fusion imaging guidance of hepatocellular carcinoma without conspicuity on conventional or contrast-enhanced US: surrounding anatomical landmarks matter.
Calandri M; Ruggeri V; Carucci P; Mirabella S; Veltri A; Fonio P; Gazzera C
Radiol Med; 2019 Oct; 124(10):1043-1048. PubMed ID: 31270723
[TBL] [Abstract][Full Text] [Related]
15. Planning Sonography Using Real-time Virtual Sonography and Contrast-enhanced Sonography for Radiofrequency Ablation of Inconspicuous Hepatocellular Carcinoma Nodules.
Toshikuni N; Takuma Y; Tomokuni J; Yamamoto H
Hepatogastroenterology; 2015 May; 62(139):661-6. PubMed ID: 26897949
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results.
Du J; Li HL; Zhai B; Chang S; Li FH
Ultrasound Med Biol; 2015 Sep; 41(9):2400-11. PubMed ID: 26055968
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography.
Rhim H; Choi D; Kim YS; Lim HK; Choe BK
Eur J Radiol; 2010 Aug; 75(2):253-8. PubMed ID: 19427152
[TBL] [Abstract][Full Text] [Related]
18. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
Lee SJ; Won HJ; Kim KW; Shin YM; Kim PN
J Clin Ultrasound; 2017 Sep; 45(7):383-390. PubMed ID: 28271531
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations.
Lee CH; Chen WT; Lin CC; Teng W; Lin SM; Chiu CT
Kaohsiung J Med Sci; 2015 Aug; 31(8):413-9. PubMed ID: 26228280
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation for viable hepatocellular carcinoma around retained iodized oil after transcatheter arterial chemoembolization: usefulness of biplane fluoroscopy plus ultrasound guidance.
Min JH; Lee MW; Rhim H; Choi D; Kim YS; Kim YJ; Cha DI; Lim HK
Korean J Radiol; 2012; 13(6):784-94. PubMed ID: 23118578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]